Pathology of peripheral T-cell lymphomas: where do we stand?

Peripheral T-cell lymphomas (PTCLs) are heterogeneous and uncommon malignancies characterized by a usually aggressive clinical course. The current World Health Organization (WHO) classification delineates many entities grouped according to the clinical presentation as predominantly leukemic, cutaneous, extranodal, or nodal diseases. Yet, few genetic lesions serve as entity-defining markers. Using high-throughput methods, new recurrent genetic and molecular alterations are being discovered that are expected to refine the current classification and serve as diagnostic genetic markers and targets for novel therapies. There is increasing evidence that certain cellular subsets, in particular follicular helper T cells and gamma delta T cells, represent important defining markers and/or determinants of the biology of certain entities; nevertheless, the cellular derivation of many PTCL entities remains poorly characterized and there is evidence of plasticity in terms of cellular derivation (alpha-beta, gamma-delta, natural killer [NK]) especially in several extranodal entities with a cytotoxic profile. While most clonal NK/T-cell proliferations are in general highly malignant, some more indolent forms of NK or T-cell lympho-proliferations are being identified.

[1]  Gustav Stålhammar,et al.  Low concordance of biomarkers in histopathological and cytological material from breast cancer , 2014, Histopathology.

[2]  W. Klapper,et al.  Peripheral T‐cell and NK‐cell lymphomas and their mimics; taking a step forward – report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology , 2014, Histopathology.

[3]  P. Gaulard,et al.  CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features , 2013, Haematologica.

[4]  E. Jaffe,et al.  Peripheral T-cell Lymphomas of Follicular T-Helper Cell Derivation With Hodgkin/Reed-Sternberg Cells of B-cell Lineage: Both EBV-positive and EBV-negative Variants Exist , 2013, The American journal of surgical pathology.

[5]  S. Swerdlow,et al.  Non-mycosis fungoides cutaneous T-cell lymphomas: report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop. , 2013, American journal of clinical pathology.

[6]  M. Piris,et al.  TCR-&ggr; Expression in Primary Cutaneous T-cell Lymphomas , 2013, The American journal of surgical pathology.

[7]  R. Lai,et al.  The pathobiology of the oncogenic tyrosine kinase NPM-ALK: a brief update , 2013, Therapeutic advances in hematology.

[8]  W. Klapper,et al.  ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study , 2013, Haematologica.

[9]  C. Copie-Bergman,et al.  Follicular Peripheral T-cell Lymphoma Expands the Spectrum of Classical Hodgkin Lymphoma Mimics , 2012, The American journal of surgical pathology.

[10]  P. Gaulard,et al.  Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte trials. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  David I. Smith,et al.  Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas. , 2012, Blood.

[12]  P. Gaulard,et al.  Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters. , 2012, Blood.

[13]  Francesco Bertoni,et al.  Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma. , 2012, Blood.

[14]  A. Feldman,et al.  Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders , 2012, Modern Pathology.

[15]  M. Amin,et al.  Anaplastic Large Cell Lymphoma Associated With Breast Implants: A Report of 13 Cases , 2012, The American journal of surgical pathology.

[16]  P. Gaulard,et al.  Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets. , 2012, Blood.

[17]  P. Gaulard,et al.  New biomarkers in T-cell lymphomas. , 2012, Best practice & research. Clinical haematology.

[18]  W. Chan,et al.  IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. , 2012, Blood.

[19]  Christian Bastard,et al.  TET2 and DNMT3A mutations in human T-cell lymphoma. , 2012, The New England journal of medicine.

[20]  P. Gaulard,et al.  c‐Maf expression in angioimmunoblastic T‐cell lymphoma reflects follicular helper T‐cell derivation rather than oncogenesis , 2012, Histopathology.

[21]  W. Klapper,et al.  Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  S. Wan,et al.  Type II Enteropathy-Associated T-Cell Lymphoma: A Distinct Aggressive Lymphoma With Frequent &ggr;&dgr; T-cell Receptor Expression , 2011, The American journal of surgical pathology.

[23]  P. Gaulard,et al.  Nonhepatosplenic &ggr;&dgr; T-cell Lymphomas Represent a Spectrum of Aggressive Cytotoxic T-cell Lymphomas With a Mainly Extranodal Presentation , 2011, The American journal of surgical pathology.

[24]  P. Gaulard,et al.  Follicular helper T cells: implications in neoplastic hematopathology. , 2011, Seminars in diagnostic pathology.

[25]  B. Nathwani,et al.  Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. , 2011, Blood.

[26]  S. Pileri,et al.  Enteropathy-associated T-cell lymphoma. , 2011, Critical reviews in oncology/hematology.

[27]  A. Feldman,et al.  Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies , 2011, Modern Pathology.

[28]  David I. Smith,et al.  Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing. , 2011, Blood.

[29]  S. Lade,et al.  Effusion-associated anaplastic large cell lymphoma of the breast: time for it to be defined as a distinct clinico-pathological entity , 2010, Haematologica.

[30]  A. Rosenwald,et al.  Disturbed expression of the T-cell receptor/CD3 complex and associated signaling molecules in CD30+ T-cell lymphoproliferations , 2010, Haematologica.

[31]  J. Holch,et al.  The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma , 2010, The Journal of experimental medicine.

[32]  Enzo Medico,et al.  Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  E. Jaffe,et al.  Cutaneous presentation of ALK-positive anaplastic large cell lymphoma following insect bites: evidence for an association in five cases , 2010, Haematologica.

[34]  P. Gaulard,et al.  Advances in the understanding and management of angioimmunoblastic T‐cell lymphoma , 2010, British journal of haematology.

[35]  P. Gaulard,et al.  Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type. , 2010, Blood.

[36]  W. Chan,et al.  Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. , 2010, Blood.

[37]  A. Feldman,et al.  PAX5-positive T-cell Anaplastic Large Cell Lymphomas Associated with Extra Copies of the PAX5 Gene Locus , 2010, Modern Pathology.

[38]  S. Pileri,et al.  Gamma-delta T-cell lymphomas , 2009, Nature Reviews Clinical Oncology.

[39]  P. Gaulard,et al.  STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma , 2009, Leukemia.

[40]  C. Copie-Bergman,et al.  Peripheral T-cell Lymphomas With a Follicular Growth Pattern are Derived From Follicular Helper T Cells (TFH) and may Show Overlapping Features With Angioimmunoblastic T-cell Lymphomas , 2009, The American journal of surgical pathology.

[41]  D. Weisenburger,et al.  Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. , 2009, Blood.

[42]  E. Campo,et al.  Primary Cutaneous CD4+ Small/Medium-sized Pleomorphic T-cell Lymphoma Expresses Follicular T-cell Markers , 2009, The American journal of surgical pathology.

[43]  M. Piris,et al.  Peripheral T-cell Lymphoma With Follicular T-cell Markers , 2008, The American journal of surgical pathology.

[44]  R. deLeeuw,et al.  Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies , 2009, Leukemia.

[45]  A. Feldman,et al.  Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas , 2008, Leukemia.

[46]  D. Weisenburger,et al.  International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  Stefano A Pileri,et al.  ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. , 2008, Blood.

[48]  R. Gascoyne,et al.  Genomic profiling reveals different genetic aberrations in systemic ALK‐positive and ALK‐negative anaplastic large cell lymphomas , 2008, British journal of haematology.

[49]  P. Gaulard,et al.  Histologic Evolution of Angioimmunoblastic T-cell Lymphoma in Consecutive Biopsies: Clinical Correlation and Insights Into Natural History and Disease Progression , 2007, The American journal of surgical pathology.

[50]  Christian Gisselbrecht,et al.  The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. , 2007, Blood.

[51]  R. Gascoyne,et al.  Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. , 2007, Gastroenterology.

[52]  P. Gaulard,et al.  Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes. , 2007, Blood.

[53]  P. Gaulard,et al.  Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: A Groupe d'Etude des Lymphomes de l'Adulte (GELA) study. , 2006, Blood.

[54]  R. Siebert,et al.  Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma , 2006, Leukemia.

[55]  Y. Kagami,et al.  Clinicopathologic and Prognostic Significance of Cytotoxic Molecule Expression in Nodal Peripheral T-Cell Lymphoma, Unspecified , 2005, The American journal of surgical pathology.

[56]  H. Müller-Hermelink,et al.  Nodal peripheral T-cell lymphomas and, in particular, their lymphoepithelioid (Lennert’s) variant are often derived from CD8+ cytotoxic T-cells , 2004, Virchows Archiv.

[57]  P. Gaulard,et al.  Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients , 2003 .

[58]  N. Harris,et al.  Peripheral T-Cell Lymphoma With Follicular Involvement and a CD4+/bcl-6+ Phenotype , 2001, The American journal of surgical pathology.

[59]  E. Macintyre,et al.  Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma , 2000, The Lancet.

[60]  E. Jaffe,et al.  Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection. , 1999, The American journal of surgical pathology.

[61]  A. Chott,et al.  Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology. , 1998, The American journal of pathology.

[62]  C. Copie-Bergman,et al.  Nonhepatosplenic γδ T-Cell Lymphoma: A Subset of Cytotoxic Lymphomas With Mucosal or Skin Localization , 1998 .

[63]  W. Wilson,et al.  The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease. , 1997, Blood.

[64]  P. Isaacson,et al.  Molecular analysis of T-cell clonality in ulcerative jejunitis and enteropathy-associated T-cell lymphoma. , 1997, The American journal of pathology.